AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2013

Oct 11, 2013

34129_dirs_2013-10-11_0fcc5c48-17e3-4bfb-a9cd-0a958b719dda.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2013-10-09

Reporting Person: Galbraith Kenneth (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-10-09	Stock Option (right to buy)	$16.00	A	13849	Acquired	2023-10-09	Common Stock (13849)	Direct

Footnotes

F1: 33.33% of the option becomes exercisable on October 9, 2014, and the remainder of the option vests in substantially equal annual installments.